Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea

Table 1 Baseline characteristics and Helicobacter pylori eradication rates due to moxifloxacin triple therapy

	Moxifloxacin-containing triple therapy as second line	P value1
Total eradication rate	73.9% (195/264)
Clinical factors
Gender		0.794
Male	74.6% (94/126)
Female	73.2% (101/138)
Age		0.965
< 45	74.2% (23/31)
≥ 45	73.8% (172/233)
Smoking		0.575
Current smoker	77.1% (37/48)
Non-smoker	73.1% (158/216)
Alcohol		0.356
Current drinker	69.4% (43/62)
Non-drinker	75.2% (152/202)
Comorbidity
HTN	69.4% (34/49)	0.429
DM	90.5% (19/21)	0.076
Disease status		0.046
Peptic ulcer (DU/GU)	82.9% (58/70)
Non-ulcer	70.6% (137/194)

¹Pearson's χ² test. HTN: Hypertension; DM: Diabetes mellitus; DU: Duodenal ulcer; GU: Gastric ulcer.